Open AccessSerotonin Syndrome Associated with Antidepressant Discontinuation in a Neonate Following Drug Exposure During Pregnancy
Author(s) -
Dolma Gurung,
Sunil Borah,
Sameer Wangu
Publication year - 2021
Publication title -
international healthcare research journal
Language(s) - English
Resource type - Journals
ISSN - 2456-8090
DOI - 10.26440/ihrj/0505.08450
Subject(s) - discontinuation , venlafaxine , antidepressant , pregnancy , medicine , depression (economics) , intervention (counseling) , drug , psychiatry , anesthesia , serotonin syndrome , pediatrics , psychology , anxiety , serotonin , genetics , receptor , macroeconomics , biology , serotonergic , economics
Sudden withdrawal of some drugs leads to withdrawal issues. We describe a baby girl who was indirectly exposed to venlafaxine as her mother was administered this drug during pregnancy for treatment of depression. The subject presented with involuntary movement of the limbs. The mother had also encountered similar scenario along with some other symptoms after she suddenly discontinued her medication. The symptoms of the mother completely resolved a few hours after the she took another dose of venlafaxine. The baby was kept under observation and recovered completely without any intervention. We suggest that healthcare professionals should be aware that patients may require tapering of anti-depressants before discontinuation.